Dr. Shobi Sivathamboo is internationally recognised for her work on sudden unexpected death in epilepsy (SUDEP). She leads the SUDEP research group at Monash University, which has a focus on uncovering the incidence and biomarkers for SUDEP risk. She completed her PhD at the University of Melbourne in 2019, which focused on examining cardiorespiratory function in epilepsy, and the relevance this has for SUDEP.

She has obtained >$250K worth of grants and funding from several peer reviewed national and international funding bodies and >$400K in industry funding. She has published in several leading peer-reviewed journals and been an invited speaker at various national and international forums, including the International Epilepsy Congress, Epilepsy Society of Australia, and the Canadian League Against Epilepsy. She is a member of the International League Against Epilepsy (ILAE) SUDEP Task Force.

She leads a number of wearable studies at The Alfred Hospital and Royal Melbourne Hospital for seizure detection and prediction, with the goal of developing interventions for SUDEP prevention. She co-leads the largest global efforts to study biomarkers with Prof. Orrin Devinsky and Prof. Daniel Friedman (New York University) to examine ECG and EEG biomarkers for SUDEP risk; this study will collect data across four continents and 86 international tertiary epilepsy centres.